search
Back to results

The Role of Smoking and Gingival Crevicular Fluid Markers on Coronally Advanced Flap Outcomes

Primary Purpose

Gingival Recession, Smoking

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Coronally Advanced Flap
Sponsored by
Ege University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gingival Recession focused on measuring Gingival crevicular fluid, Gingival recession, Saliva, Smoking, Wound healing

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Maxillary central and lateral incisors, canines, and premolars and mandibular premolars with isolated buccal recessions classified as Miller Class I or II
  • Study tooth should present tooth vitality, identifiable cemento-enamel junction (CEJ) and absence of caries, restorations or extensive non-carious cervical lesion.

Exclusion Criteria:

  • Medical disorders such as diabetes mellitus, immunologic disorders, hepatitis
  • History of previous mucogingival surgery at the gingival recession site
  • Medications known to affect gingival tissues
  • Antibiotic treatment in the past 6 months
  • Pregnancy or lactation

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Smoker Group

    Non-smoker Group

    Arm Description

    This group included smoker gingival recession patients.

    This group included non-smoker gingival recession patients.

    Outcomes

    Primary Outcome Measures

    Change in the percentage of root coverage
    Root coverage were measured on digital photographs using specific software.

    Secondary Outcome Measures

    Change in the percentage of complete root coverage
    Change in gingival thickness
    Gingival thickness was measured with an ultrasonic device that uses the pulse echo principle. Ultrasonic pulses are transmitted at intervals of 1 millisecond through the sound-permeable mucosa and reflected, in part, at the surface of the alveolar bone or tooth attributable to different acoustic impedance. When an acoustic signal is transmitted within 2 to 3 seconds, gingival thickness is digitally displayed with a sensitivity of 0.01 mm.
    Changing of the gingival crevicular fluid (GCF) biomarkers
    Changing of the salivary biomarkers
    Change in the visual analog scale (VAS) values
    The visual analog scale (VAS) was used to evaluate pain during the postoperative follow-up period. It consists of a straight line with the endpoints defining extreme limits such as 'no pain at all' and 'pain as bad as it could be'. The patient selects a whole number (0-10 integers) that best reflects the intensity of their pain, with 0 being the no pain and 10 being the worst pain.

    Full Information

    First Posted
    May 15, 2018
    Last Updated
    May 25, 2018
    Sponsor
    Ege University
    Collaborators
    University of Louisville
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03539939
    Brief Title
    The Role of Smoking and Gingival Crevicular Fluid Markers on Coronally Advanced Flap Outcomes
    Official Title
    The Role of Smoking and Gingival Crevicular Fluid Markers on Coronally Advanced Flap Outcomes
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2018
    Overall Recruitment Status
    Completed
    Study Start Date
    May 3, 2010 (Actual)
    Primary Completion Date
    June 7, 2012 (Actual)
    Study Completion Date
    January 7, 2013 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Ege University
    Collaborators
    University of Louisville

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Cigarette smoking is a patient-related factor that can affect healing of periodontal tissues and the success rate of root-coverage procedures. Neither the nature nor the mechanisms of action of cigarette smoking on root coverage are fully understood. Therefore, the hypothesis that cigarette smoking has negative impacts on the outcomes of root coverage after CAF surgery in systemically healthy individuals with an initial gingival thickness of at least 0.8 mm and who practice optimal oral hygiene was tested. It was also hypothesized that baseline analysis of disease-related biomarkers would shed light on the underlying mechanisms of a possible effect.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Gingival Recession, Smoking
    Keywords
    Gingival crevicular fluid, Gingival recession, Saliva, Smoking, Wound healing

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    15 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Smoker Group
    Arm Type
    Experimental
    Arm Description
    This group included smoker gingival recession patients.
    Arm Title
    Non-smoker Group
    Arm Type
    Active Comparator
    Arm Description
    This group included non-smoker gingival recession patients.
    Intervention Type
    Procedure
    Intervention Name(s)
    Coronally Advanced Flap
    Intervention Description
    The coronally advanced flap (CAF) is a procedure frequently used in periodontal plastic surgery. The main objective of this surgical technique is to mobilize the gingival margin and reposition it at a level more coronal (incisal direction) than its original location. CAF is mainly used for the treatment of gingival recessions.
    Primary Outcome Measure Information:
    Title
    Change in the percentage of root coverage
    Description
    Root coverage were measured on digital photographs using specific software.
    Time Frame
    1-month, 3-month and 6-month after coronally advanced flap (CAF)
    Secondary Outcome Measure Information:
    Title
    Change in the percentage of complete root coverage
    Time Frame
    1-month, 3-month and 6-month after coronally advanced flap (CAF)
    Title
    Change in gingival thickness
    Description
    Gingival thickness was measured with an ultrasonic device that uses the pulse echo principle. Ultrasonic pulses are transmitted at intervals of 1 millisecond through the sound-permeable mucosa and reflected, in part, at the surface of the alveolar bone or tooth attributable to different acoustic impedance. When an acoustic signal is transmitted within 2 to 3 seconds, gingival thickness is digitally displayed with a sensitivity of 0.01 mm.
    Time Frame
    Baseline,1-month, 3-month and 6-month after coronally advanced flap (CAF)
    Title
    Changing of the gingival crevicular fluid (GCF) biomarkers
    Time Frame
    Baseline,1-month, 3-month and 6-month after coronally advanced flap (CAF)
    Title
    Changing of the salivary biomarkers
    Time Frame
    Baseline,1-month, 3-month and 6-month after coronally advanced flap (CAF)
    Title
    Change in the visual analog scale (VAS) values
    Description
    The visual analog scale (VAS) was used to evaluate pain during the postoperative follow-up period. It consists of a straight line with the endpoints defining extreme limits such as 'no pain at all' and 'pain as bad as it could be'. The patient selects a whole number (0-10 integers) that best reflects the intensity of their pain, with 0 being the no pain and 10 being the worst pain.
    Time Frame
    1 to 7 day after coronally advanced flap (CAF)

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Maxillary central and lateral incisors, canines, and premolars and mandibular premolars with isolated buccal recessions classified as Miller Class I or II Study tooth should present tooth vitality, identifiable cemento-enamel junction (CEJ) and absence of caries, restorations or extensive non-carious cervical lesion. Exclusion Criteria: Medical disorders such as diabetes mellitus, immunologic disorders, hepatitis History of previous mucogingival surgery at the gingival recession site Medications known to affect gingival tissues Antibiotic treatment in the past 6 months Pregnancy or lactation

    12. IPD Sharing Statement

    Learn more about this trial

    The Role of Smoking and Gingival Crevicular Fluid Markers on Coronally Advanced Flap Outcomes

    We'll reach out to this number within 24 hrs